CATALYSTEM, compatible with CORI robotics, addresses the increased adoption of anterior approach procedures and the expanding role of Ambulatory Surgery Centers.
The company gained FDA approval to proceed with Phase III clinical evaluation of allogeneic, injectable disc progenitor cell therapy for symptomatic lumbar degenerative disc disease.
VisiCORE is a bone graft harvesting system for foot and ankle fusion designed with a clear collection tube with proprietary Graft Retention Technology.